Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults

John W McEvoy1, Olive Tang2, Dan Wang3

  • 1Division of Cardiology and National Institute for Prevention and Cardiovascular Health, University of Galway, Galway, Ireland; Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Insights

This study found lower-than-expected upper reference limits (URLs) for high-sensitivity troponin assays in healthy US adults. These troponin levels varied significantly by sex and age, impacting myocardial injury definitions.

Area of Science:

  • Cardiovascular diagnostics and biomarkers
  • Clinical chemistry and laboratory medicine
  • Population health and epidemiology

Background:

  • Myocardial injury is defined by cardiac troponin levels exceeding the sex-specific 99th percentile of a healthy reference population (upper reference limit [URL]).
  • Accurate troponin URLs are crucial for diagnosing myocardial injury.
  • Existing troponin assay URLs may not reflect contemporary US adult populations.

Purpose of the Study:

  • To estimate high-sensitivity (hs) troponin T and I upper reference limits (URLs) in a representative US adult sample.
  • To analyze these URLs stratified by sex, race/ethnicity, and age group.
  • To compare assay-specific URLs with manufacturer-reported values.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
  • Measured hs-troponin T (Roche) and hs-troponin I (Abbott, Siemens, Ortho) in a strictly defined healthy reference subgroup (n=2,746).
  • Estimated 99th percentile URLs using the nonparametric method.

Main Results:

  • NHANES-derived URLs for hs-troponin I assays were substantially lower than manufacturer-reported values.
  • Significant differences in URLs were observed between sexes and across age groups (<40 vs. ≥60 years).
  • No significant differences in URLs were found based on race/ethnicity.

Conclusions:

  • Established new, lower upper reference limits for hs-troponin I assays in healthy US adults.
  • Highlighted significant sex and age-related variations in troponin URLs, necessitating assay and population-specific considerations.
  • Findings suggest a need to re-evaluate current diagnostic thresholds for myocardial injury.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
206
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
24
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127